Ex-Metacrine chief Preston Klassen recharges at microRNA biotech; Allogene begins search for a CFO
→ Preston Klassen has mapped out his next destination as president and R&D chief of microRNA developer Regulus Therapeutics. Klassen was …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
